In 2022, Helena Chaytow et al. studied the efficacy of targeting PGk1 using terazosin in zebrafish, mouse and ESC-derived motor neuron models of ALS [90]. The gene discussed is PGK1; the disease is amyotrophic lateral sclerosis.